Biochemical screening.
The goal of screening both low and high risk obstetrics populations for chromosomally abnormal fetuses continues to be developed in many centers worldwide. Advances in the past year have been multifocal in their approach--neural tube detection, the development of new markers for aneuploidy, and attempts to move screening into the first trimester.
['Chromosome Aberrations/*diagnosis', 'Chromosome Disorders', 'Ethics, Medical', 'Female', 'Fetal Diseases/diagnosis/*genetics', 'Genetic Markers', '*Genetic Testing', 'Humans', 'Neural Tube Defects/*diagnosis/genetics', 'Pregnancy', '*Prenatal Diagnosis']